Clinical Trial Update: Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate the antipruritic effect of topical pimecrolimus (Elidel) in non-atopic pruritic disease (Prurigo Nodularis). The study status ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prurigo Nodularis

Drugs mentioned

• Elidel (pimecrolimus)

Snippet

Sponsor: University Hospital Muenster | Conditions: Prurigo Nodularis | Phase 2 | Status: COMPLETED